Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Profiling tumor counterattack: do Fas ligand-containing microvesicles reduce anticancer immunity?

Osnat Bohana-Kashtan¹, Curt I Civin

¹Division of Immunology and Hematopoiesis, Sidney Kimmel Comprehensive Cancer Center, Departments of Oncology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

|February 15, 2005

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

MiR-513a promotes human erythroid differentiation by modulating c-Jun.

FEBS open bio·2026

Same author

Augmenting the Anti-Leukemic Activity of the BCL-2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL-2/HDAC1 and Dual BCL-2/HDAC6 Inhibitors.

Drug development research·2025

Same author

The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN-GIL hybrid single-molecule inhibitors.

European journal of medicinal chemistry·2025

Same author

ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative.

Cancer chemotherapy and pharmacology·2023

Same author

A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology.

Frontiers in oncology·2022

Same author

Hypoxia-inducible factor 1-alpha enhances the secretome to rejuvenate adult cardiosphere-derived cells.

The Journal of thoracic and cardiovascular surgery·2021